State Street
RVLP

State Street’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

State Street’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-106,487
Closed -$9.22K – 4571
2023
Q3 		$9.22K Buy
106,487
+27,800
+35% +$8.01K ﹤0.01% 4513
2023
Q2 		$44.1K Hold
78,687
– – ﹤0.01% 4449
2023
Q1 		$89.7K Hold
78,687
– – ﹤0.01% 4350
2022
Q4 		$88.1K Buy
78,687
+6,500
+9% +$10.4K ﹤0.01% 4405
2022
Q3 		$152K Hold
72,187
– – ﹤0.01% 4256
2022
Q2 		$98K Buy
72,187
+33,403
+86% +$48.4K ﹤0.01% 4548
2022
Q1 		$66K Buy
38,784
+4,600
+13% +$6.58K ﹤0.01% 4744
2021
Q4 		$37K Hold
34,184
– – ﹤0.01% 4742
2021
Q3 		$101K Buy
34,184
+3,900
+13% +$13.1K ﹤0.01% 4545
2021
Q2 		$91K Sell
30,284
-178,419
-85% -$546K ﹤0.01% 4378
2021
Q1 		$680K Sell
208,703
-12,117
-5% -$49.8K ﹤0.01% 3695
2020
Q4 		$910K Buy
220,820
+4,551
+2% +$26.2K ﹤0.01% 3569
2020
Q3 		$1.17M Buy
216,269
+35,674
+20% +$205K ﹤0.01% 3397
2020
Q2 		$1.22M Buy
180,595
+16,275
+10% +$79.7K ﹤0.01% 3363
2020
Q1 		$523K Buy
164,320
+19,021
+13% +$101K ﹤0.01% 3439
2019
Q4 		$1.02M Buy
145,299
+24,617
+20% +$131K ﹤0.01% 3403
2019
Q3 		$463K Sell
120,682
-1,482
-1% -$5.02K ﹤0.01% 3520
2019
Q2 		$464K Buy
122,164
+15,641
+15% +$52K ﹤0.01% 3523
2019
Q1 		$383K Buy
106,523
+86,923
+443% +$640K ﹤0.01% 3479
2018
Q4 		$152K Buy
+19,600
New +$157K ﹤0.01% 3604

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

State Street's RVLP Position: Q4 2023 in Review

State Street sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 106,487 shares — an estimated $9.22K sold.

State Street first reported a position in RVLP in Q4 2018 and held it in 20 quarters. The position peaked at $1.22M in Q2 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • State Street reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • State Street sold 106,487 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $9.22K.
  • State Street first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • State Street's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.22M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.